Restelea

Indicated to treat schizophrenia; maniac or mixed episodes associated with type I bipolar disorder and irritability associated with autistic disorders.

Therapeutic Area
Antipsychotics

Active Ingredient
Risperidone

Line
Neurosciences

Pharmaceutical Forms
0,50 mg x 20 tablets
1 mg x 20 tablets
1 mg x 60 tablets
2 mg x 20 tablets
2 mg x 60 tablets
3 mg x 20 tablets
3 mg x 60 tablets

Download Leaflet Descargar